{
  "id": "5e4604d83f54159529000003",
  "type": "factoid",
  "question": "Which disease was studied in the CADISS trial?",
  "ideal_answer": "CADISS was a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/28087823",
    "http://www.ncbi.nlm.nih.gov/pubmed/18705933",
    "http://www.ncbi.nlm.nih.gov/pubmed/22855862",
    "http://www.ncbi.nlm.nih.gov/pubmed/22110554",
    "http://www.ncbi.nlm.nih.gov/pubmed/19386884",
    "http://www.ncbi.nlm.nih.gov/pubmed/30801621",
    "http://www.ncbi.nlm.nih.gov/pubmed/25684164"
  ],
  "snippets": [
    {
      "text": "Prognosis of carotid dissecting aneurysms: Results from CADISS and a systematic review.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28087823",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "METHODS: We included 264 patients with extracranial cervical artery dissection (CAD) from the Cervical Artery Dissection in Stroke Study (CADISS), a multicenter prospective study that compared antiplatelet with anticoagulation therapy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28087823",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSIONS: The results of CADISS provide evidence suggesting that DAs may have benign prognosis and therefore medical treatment should be considered.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28087823",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25684164",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "We compared their efficacy in the Cervical Artery Dissection in Stroke Study (CADISS), with the additional aim of establishing the true risk of recurrent stroke.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25684164",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: To present the results of the nonrandomized arm of the Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke after carotid and vertebral dissection, and perform a meta-analysis of these results with previously published studies comparing the 2 therapeutic strategies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22855862",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Although optimal treatment for VAD is unknown, the Cervical Artery Dissection in Stroke Study (CADISS) is an ongoing randomised multicentre prospective study comparing antiplatelet therapy with anticoagulation for patients with both carotid artery dissection and VAD. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19386884",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We use dual antiplatelets for the management of cervical dissections as a part of the CADISS trial. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22110554",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Antiplatelet therapy vs. anticoagulation in cervical artery dissection: rationale and design of the Cervical Artery Dissection in Stroke Study (CADISS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18705933",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "AIMS: CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18705933",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "AIMS\n\nCADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18705933",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We use dual antiplatelets for the management of cervical dissections as a part of the CADISS trial.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22110554",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "AIMS CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18705933",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Antiplatelet Therapy vs Anticoagulation Therapy in Cervical Artery Dissection: The Cervical Artery Dissection in Stroke Study ( CADISS ) Randomized Clinical Trial Final Results .",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30801621",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Antiplatelet therapy vs. anticoagulation in cervical artery dissection: rationale and design of the Cervical Artery Dissection in Stroke Study ( CADISS ) .",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18705933",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "We compared their efficacy in the Cervical Artery Dissection in Stroke Study ( CADISS) , with the additional aim of establishing the true risk of recurrent stroke .",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25684164",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We compared their efficacy in the Cervical Artery Dissection in Stroke Study (CADISS), with the additional aim of establishing the true risk of recurrent stroke.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25684164",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE\nTo present the results of the nonrandomized arm of the Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke after carotid and vertebral dissection, and perform a meta-analysis of these results with previously published studies comparing the 2 therapeutic strategies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22855862",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We use dual antiplatelets for the management of cervical dissections as a part of the CADISS trial.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22110554",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "AIMS\nCADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18705933",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "anticoagulation in cervical artery dissection: rationale and design of the Cervical Artery Dissection in Stroke Study (CADISS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18705933",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Antiplatelet Therapy vs Anticoagulation Therapy in Cervical Artery Dissection: The Cervical Artery Dissection in Stroke Study (CADISS) Randomized Clinical Trial Final Results.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30801621",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Although optimal treatment for VAD is unknown, the Cervical Artery Dissection in Stroke Study (CADISS) is an ongoing randomised multicentre prospective study comparing antiplatelet therapy with anticoagulation for patients with both carotid artery dissection and VAD.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19386884",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18705933",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "To present the results of the nonrandomized arm of the Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke after carotid and vertebral dissection, and perform a meta-analysis of these results with previously published studies comparing the 2 therapeutic strategies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22855862",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We compared their efficacy in the Cervical Artery Dissection in Stroke Study (CADISS), with the additional aim of establishing the true risk of recurrent stroke.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25684164",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "carotid and vertebral artery dissection"
}